Chicago, IL, June 27, 2014 --(PR.com
)-- By popular request, Q1 Productions will be hosting the inaugural Pharmaceutical Supplier Quality Assurance Conference July 21-22, in Arlington, Virginia, fulfilling the demand for a tailor-made meeting for supplier quality assurance professionals within the pharmaceutical industry. Pharmaceutical quality assurance executives are invited to take part in peer-to-peer networking, high-level information sessions and idea sharing during the two day conference and take away immediate deliverables to give their companies a competitive advantage.
The conference, focusing on implementing successful risk assessment practices and methods for supplier qualification, will offer attendees in-depth discussions with fellow pharmaceutical professionals addressing the biggest concerns surrounding the industry. A wide variety of speakers, including Michael Daly of Valeant, Glen Goff of Eisai, Dana Blobner of Ultragenyx Pharmaceuticals, and Shellyanne Sealy-Wilder of Merck are scheduled to conduct interactive presentations and panel discussions through the two-day meeting.
“Supplier quality teams are vital because their role is to ensure that raw materials provided to the facility are produced under Good Manufacturing Practices,” said Goff. “Purchasing and the supplier quality team have to have a good working relationship.”
Unique from meetings of related interest, the Pharmaceutical Supplier Quality Assurance Conference will offer speakers from backgrounds such as law, auditing, supplier development, and quality assurance and will provide a variety of perspectives to attendees. Both small and large pharmaceutical companies, as well as suppliers will be on hand for networking and interactive discussion.
For more information, or to register for this conference, please visit www.q1productions.com/rxsupplierqa. You may also follow the conference on Twitter, @Q1Productions using hashtag #q1pharmaQA.
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.